Literature DB >> 10803469

Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: the Cornell voltage.

S V de Kreutzenberg1, A Avogaro, A Tiengo, S Del Prato.   

Abstract

Both type 2 diabetes mellitus (DM2) and left ventricular hypertrophy are associated with an increased risk of cardiovascular diseases (CVD). A strong association between hyperinsulinemia, which is the hallmark of DM2 and of insulin resistance syndrome (a cohort of metabolic abnormalities such as DM2, dyslipidemia, hyperuricemia, obesity, hypertension, hyperfibrinogenemia), and left ventricular (LV) hypertrophy was found in several studies. We studied 140 consecutive (both normo- and hypertensive) DM2 patients to determine a possible link between metabolic features and the degree of LV mass, calculated by the ECG method of Cornell voltage. The Cornell voltage value was 12.9+/-0.5 mm in the DM2 population as a whole, and 13.6+/-0.7 vs 11.7+/-0.9 mm (p=NS) in hypertensive and normotensive DM2 subgroups, respectively. Among all the metabolic parameters taken into account, the multivariate analysis shows that the fasting plasma insulin level is the strongest independent predictor of LV mass, both in the whole population (p=0.0005) and in the normo (p=0.0460) and hypertensive DM2 (p=0.0184) subgroups.

Entities:  

Mesh:

Year:  2000        PMID: 10803469     DOI: 10.1007/BF03343696

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Prospective analysis of the insulin-resistance syndrome (syndrome X).

Authors:  S M Haffner; R A Valdez; H P Hazuda; B D Mitchell; P A Morales; M P Stern
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

2.  A simple measure of insulin resistance.

Authors:  M H Duncan; B M Singh; P H Wise; G Carter; J Alaghband-Zadeh
Journal:  Lancet       Date:  1995-07-08       Impact factor: 79.321

Review 3.  The effect of insulin on renal sodium metabolism. A review with clinical implications.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Improved detection of echocardiographic left ventricular hypertrophy using a new electrocardiographic algorithm.

Authors:  J E Norman; D Levy; G Campbell; J J Bailey
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

6.  Insulin resistance is an important determinant of left ventricular mass in the obese.

Authors:  Z Sasson; Y Rasooly; T Bhesania; I Rasooly
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

7.  Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance.

Authors:  P H McNulty; R J Louard; L I Deckelbaum; B L Zaret; L H Young
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

8.  How good a marker is insulin level for insulin resistance?

Authors:  M Laakso
Journal:  Am J Epidemiol       Date:  1993-05-01       Impact factor: 4.897

9.  Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study.

Authors:  F N Brand; R D Abbott; W B Kannel
Journal:  Diabetes       Date:  1989-04       Impact factor: 9.461

10.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.

Authors:  I Zavaroni; E Bonora; M Pagliara; E Dall'Aglio; L Luchetti; G Buonanno; P A Bonati; M Bergonzani; L Gnudi; M Passeri
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

View more
  2 in total

1.  Development of metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects.

Authors:  M Rigato; F Boscari; G Marcuzzo; S Vigili de Kreutzenberg; M C Marescotti; A Avogaro; G P Fadini
Journal:  J Endocrinol Invest       Date:  2013-07-15       Impact factor: 4.256

Review 2.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.